0001209191-19-021602.txt : 20190328
0001209191-19-021602.hdr.sgml : 20190328
20190328152844
ACCESSION NUMBER: 0001209191-19-021602
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190328
FILED AS OF DATE: 20190328
DATE AS OF CHANGE: 20190328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Khan Gulam Amjad
CENTRAL INDEX KEY: 0001651656
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38848
FILM NUMBER: 19711688
MAIL ADDRESS:
STREET 1: 5960 HEISLEY ROAD
CITY: MENTOR
STATE: OH
ZIP: 44060
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: STERIS Ltd
CENTRAL INDEX KEY: 0001757898
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 70 SIR JOHN ROGERSON'S QUAY
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: 35312322454
MAIL ADDRESS:
STREET 1: 70 SIR JOHN ROGERSON'S QUAY
CITY: DUBLIN
STATE: L2
ZIP: 2
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-28
0
0001757898
STERIS Ltd
STE
0001651656
Khan Gulam Amjad
C/O 70 SIR JOHN ROGERSON'S QUAY
DUBLIN
L2
2
IRELAND
0
1
0
0
Sr. V.P., Procedural Solutions
Ordinary Shares
2019-03-28
4
A
0
15864
A
15864
D
Employee Stock Option (right to buy)
65.05
2019-03-28
4
A
0
11700
A
2025-08-27
Ordinary Shares
11700
11700
D
Employee Stock Option (right to buy)
69.72
2019-03-28
4
A
0
15000
A
2026-06-01
Ordinary Shares
15000
15000
D
Employee Stock Option (right to buy)
77.07
2019-03-28
4
A
0
15000
A
2027-05-30
Ordinary Shares
15000
15000
D
Employee Stock Option (right to buy)
114.22
2019-03-28
4
A
0
20536
A
2028-05-31
Ordinary Shares
20536
20536
D
All 15,864 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 2,500 on June 1, 2020; 4,500 on June 1, 2021 and 1,864 on May 31, 2022.
Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
This option become exercisable as follows: 2,925 on May 28, 2016; 2,925 on May 28, 2017; 2,925 on May 28, 2018 and 2,925 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 11,700 STERIS ordinary shares for $65.05 per share, subject to the same terms and conditions as the original Old STERIS stock option.
This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 15,000 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option.
This option becomes exercisable as follows: 3,750 on May 30, 2018;3,750 on May 30, 2019; 3,750 on June 1, 2020 and 3,750 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 15,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option.
This option becomes exercisable as follows: 5,134 on May 31, 2019; 5,134 on June 1, 2020; 5,134 on June 1, 2021 and 5,134 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 20,536 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option.
s/ Ronald E. Snyder, Authorized Representative under Power of Attorney
2018-03-28